Close

AbbVie (ABBV) Tops Q4 EPS by 6c, Offers FY Guidance

Go back to AbbVie (ABBV) Tops Q4 EPS by 6c, Offers FY Guidance

AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results

February 3, 2021 7:38 AM EST

NORTH CHICAGO, Ill., Feb. 3, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced financial results for the fourth quarter and full year ended December 31, 2020.

"We successfully completed the transformative Allergan acquisition and delivered another year of strong results in 2020, despite the challenges presented by the global pandemic," said Richard A. Gonzalez, chairman and chief executive officer, AbbVie. "Based on our broad portfolio of diversified growth assets and the robust momentum of our business, we expect impressive growth again in 2021."

Fourth-Quarter Results

Worldwide net revenues were $13.858... More